CD274 and neoplasm: Man@pSiNP‐erastin or anti‐PD‐L1 treatment alone effectively attenuated tumor growth and development, and importantly, the combination of Man@pSiNPs‐erastin and anti‐PD‐L1 treatment achieved optimal anticancer efficacy (Figure 8A–E).